Overview A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity Status: Not yet recruiting Trial end date: 2025-01-22 Target enrollment: Participant gender: Summary The aim of the study is to evaluate the efficacy and safety of XW003 versus placebo in adults with overweight or obesity Phase: Phase 3 Details Lead Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.